Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 125


Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: a population-based case-control study.

Bodelon C, Madeleine MM, Johnson LG, Du Q, Galloway DA, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2014 Jan 15;134(2):437-44. doi: 10.1002/ijc.28364. Epub 2013 Aug 5.


Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.

Bodelon C, Madeleine MM, Johnson LG, Du Q, Malkki M, Petersdorf EW, Schwartz SM.

Gynecol Oncol. 2012 Mar;124(3):525-8. doi: 10.1016/j.ygyno.2011.11.017. Epub 2011 Nov 28.


Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2013 Jul;133(1):201-13. doi: 10.1002/ijc.28000. Epub 2013 Feb 12.


A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.

Hardikar S, Johnson LG, Malkki M, Petersdorf EW, Galloway DA, Schwartz SM, Madeleine MM.

Gynecol Oncol. 2015 Oct;139(1):90-6. doi: 10.1016/j.ygyno.2015.07.110. Epub 2015 Aug 1.


Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.

Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, Kay NE, Dogan A, Liebow M, Wang AH, Call TG, Habermann TM, Ansell SM, Slager SL.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3161-9. doi: 10.1158/1055-9965.EPI-08-0536.


Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Malkki M, Wilkerson HW, Farin FM, Carter JJ, Galloway DA, Daling JR, Petersdorf EW, Schwartz SM.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1790-9. doi: 10.1158/1055-9965.EPI-07-2753.


Epidermal growth factor genetic variation associated with advanced cervical cancer in younger women.

Araújo AP, Catarino R, Ribeiro R, Pereira D, Pinto D, Medeiros R.

Am J Clin Oncol. 2012 Jun;35(3):247-50. doi: 10.1097/COC.0b013e31820dbbf5.


Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.

Zidi S, Verdi H, Yilmaz-Yalcin Y, Yazici AC, Gazouani E, Mezlini A, Atac FB, Yacoubi-Loueslati B.

Bull Cancer. 2014 Oct;101(10):E31-5. doi: 10.1684/bdc.2014.2037.


Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study.

Maley SN, Schwartz SM, Johnson LG, Malkki M, Du Q, Daling JR, Li SS, Zhao LP, Petersdorf EW, Madeleine MM.

Int J Immunogenet. 2009 Dec;36(6):367-75. doi: 10.1111/j.1744-313X.2009.00877.x. Epub 2009 Sep 24.


Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.

Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, Armstrong BK, Lan Q, Hartge P, Kricker A, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Grulich A, Leaderer BP, Davis S, Cozen W, Yeager M, Chanock SJ, Chatterjee N, Rothman N.

PLoS One. 2009;4(4):e5360. doi: 10.1371/journal.pone.0005360. Epub 2009 Apr 24.


Cofactors with human papillomavirus in a population-based study of vulvar cancer.

Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B, Kurman RJ, Beckmann AM, Hagensee ME, Galloway DA.

J Natl Cancer Inst. 1997 Oct 15;89(20):1516-23. Erratum in: J Natl Cancer Inst 1997 Dec 17;89(24):1896.


Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study.

Resler AJ, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, Madeleine MM.

BMC Cancer. 2013 May 1;13:219. doi: 10.1186/1471-2407-13-219.


TNF-α -308 G/A as a risk marker of cervical cancer progression in the Polish population.

Roszak A, Misztal M, Sowińska A, Jagodziński PP.

Mol Diagn Ther. 2015 Feb;19(1):53-7. doi: 10.1007/s40291-015-0130-y.


Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer.

Lai ZZ, Ni-Zhang, Pan XL, Song L.

J Int Med Res. 2013 Aug;41(4):1027-36. doi: 10.1177/0300060513483398. Epub 2013 Jul 1.


Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.

Chen D, Gyllensten U.

Carcinogenesis. 2014 Aug;35(8):1765-9. doi: 10.1093/carcin/bgu096. Epub 2014 Apr 17.


Association of constitutive nuclear factor-kappaB activation with aggressive aspects and poor prognosis in cervical cancer.

Li J, Jia H, Xie L, Wang X, Wang X, He H, Lin Y, Hu L.

Int J Gynecol Cancer. 2009 Nov;19(8):1421-6. doi: 10.1111/IGC.0b013e3181b70445.


Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.

Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Lal P, Mittal RD.

Mol Biol Rep. 2011 Oct;38(7):4715-21. doi: 10.1007/s11033-010-0607-z. Epub 2010 Dec 5.


Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States.

Zelmanowicz Ade M, Schiffman M, Herrero R, Goldstein AM, Sherman ME, Burk RD, Gravitt P, Viscidi R, Schwartz P, Barnes W, Mortel R, Silverberg SG, Buckland J, Hildesheim A.

Int J Cancer. 2005 Sep 10;116(4):599-605.


Upregulation of nuclear factor-kappaB (NF-kappaB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Syrjänen S, Favalli C, Syrjänen K; HPV-Pthogen ISS Study Group.

Diagn Cytopathol. 2006 Aug;34(8):555-63.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk